🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "specific measures to deal with household expense issues" in the upcoming financial statement.

During an interview with the BBC, she emphasized that lowering inflation is a shared responsibility of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the G7 advanced economies this calendar year and the following year.

Potential Energy Bill Measures

Reports indicate the administration could intervene to bring down utility costs, for example by reducing the present 5% rate of value-added tax applied on energy.

A further approach is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such actions.

The expectation from the majority of analysts is that Reeves will have to declare tax rises or expenditure reductions in order to meet her self-imposed debt limits.

Earlier on Thursday, estimates showed there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of expectations.

"It is a shared job between the Bank of England and the government to bear down further on some of the sources of price increases," the Chancellor told reporters in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on probable tax rises, the Treasury chief said the most recent figures from the OBR had not altered her commitment to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing international and commercial concerns for the fiscal revenue measures, probably to be focused on those "with the broadest shoulders."

Global Trade Tensions

Referring to apprehensions about the United Kingdom's commercial links with China she said: "Our national security always come first."

Recent statement by China to strengthen export controls on critical minerals and other materials that are crucial for high-technology production led US President Donald Trump to threaten an further 100% import tax on imports from China, raising the risk of an all-out trade war between the two economic giants.

The American finance chief called the Chinese action "commercial pressure" and "a global supply chain control attempt."

Asked about considering the American proposal to participate in its battle with China, the Chancellor said she was "very concerned" by Chinese measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and causes further challenges."

"It is my opinion there are areas where we must confront China, but there are also important opportunities to trade with China's economy, including financial services and other sectors of the economy. We've got to get that balance appropriate."

The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources approach, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for pharmaceuticals could go up as a result of current talks with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global drug companies have said in recent statements that they are either delaying or scrapping investments in the UK, with several attributing the low prices they are obtaining.

Recently, the Science Minister said the price the NHS pays for medicines would have to increase to prevent companies and drug research funding leaving the UK.

The Chancellor told the BBC: "It has been observed as a result of the payment system, that drug testing, innovative medicines have not been offered in the United Kingdom in the extent that they are in other EU nations."

"We want to make sure that people receiving treatment from the National Health Service are can receive the best critical treatments in the world. And so we are looking at these issues, and... looking to attract more capital into Britain."